Detalhe da pesquisa
1.
Molecular disparity of HLA-DPB1 is associated with the development of subsequent solid cancer after allogeneic hematopoietic stem cell transplantation.
Cancer
; 129(8): 1205-1216, 2023 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36738229
2.
Development and validation of a patient-reported outcome measure to assess symptom burden after chimeric antigen receptor T-cell therapy.
Br J Haematol
; 201(4): 738-746, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36733986
3.
Is There Still a Role for Transplant for Patients with Mantle Cell Lymphoma (MCL) in the Era of CAR-T Cell Therapy?
Curr Treat Options Oncol
; 23(11): 1614-1625, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36227407
4.
Chimeric antigen receptor T-cell therapy toxicities.
Br J Clin Pharmacol
; 87(6): 2414-2424, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32463929
5.
Cytogenetics and Blast Count Determine Transplant Outcomes in Patients with Active Acute Myeloid Leukemia.
Acta Haematol
; 144(1): 74-81, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-32604096
6.
Endothelial Activation and Stress Index (EASIX) at Admission Predicts Fluid Overload in Recipients of Allogeneic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 26(5): 1013-1020, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32045652
7.
Chimeric Antigen Receptor Therapy: How Are We Driving in Solid Tumors?
Biol Blood Marrow Transplant
; 26(10): 1759-1769, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32623078
8.
Haploidentical transplants for patients with relapse after the first allograft.
Am J Hematol
; 95(10): 1187-1192, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32619033
9.
Comparison of Outcomes of Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma Using Three Different Conditioning Regimens.
Biol Blood Marrow Transplant
; 25(5): 1039-1044, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30639822
10.
Real-world analysis of safety and efficacy of CAR T-cell therapy in lymphoma patients with decreased kidney function.
Br J Haematol
; 204(1): e11-e16, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37822075
11.
Haploidentical transplantation for acute myeloid leukemia patients with minimal/measurable residual disease at transplantation.
Am J Hematol
; 94(12): 1382-1387, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31595538
12.
Four-year follow-up of a single arm, phase II clinical trial of ibrutinib with rituximab (IR) in patients with relapsed/refractory mantle cell lymphoma (MCL).
Br J Haematol
; 182(3): 404-411, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29785709
13.
Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for High-Risk Acute Lymphoblastic Leukemia.
Biol Blood Marrow Transplant
; 23(2): 318-324, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27856368
14.
A randomized phase II study of standard-dose versus high-dose rituximab with BEAM in autologous stem cell transplantation for relapsed aggressive B-cell non-hodgkin lymphomas: long term results.
Br J Haematol
; 178(4): 561-570, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28485023
15.
A myeloablative fractionated busulfan conditioning regimen with post-transplant cyclophosphamide in HLA-matched and haploidentical transplantation: results of a phase II study.
Haematologica
; 107(10): 2496-2500, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35770531
16.
Outcome of Patients with Multiple Myeloma and CKS1B Gene Amplification after Autologous Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 22(12): 2159-2164, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27638366
17.
Incidence and patient survival of myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms in the United States, 2001-12.
Br J Haematol
; 174(3): 382-96, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27061824
18.
Mixed myeloid chimerism and relapse of myelofibrosis after allogeneic stem cell transplantation.
Haematologica
; 106(7): 1988-1990, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31296578
19.
Melphalan dose intensity for autologous stem cell transplantation in multiple myeloma.
Haematologica
; 106(12): 3211-3214, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34407606
20.
Impact of Mixed Chimerism on Myelofibrosis Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 26(12): e301-e302, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32949752